Using a Microstructure-Property Approach to 'De-Risk' Pharmaceutical Formulations
Date: Thursday, April 11, 2013
Time: 9:00 AM EDT / 1:00 PM GMT
Pharmaceutical formulation is a complex process that is full of risk. The interactions among ingredients can affect product quality. It is essential to understand the materials science principles behind each constituent ingredient and how they interact to ensure that risk is controlled and quality optimized.
In this program you will:
Webinar Archive Registration
To register for this webinar, please complete the form below. Take care to provide all required information (indicated in red). Press Register to complete your registration. If you have already registered for our site or for one of our webinars, you may login to register without re-entering your information.
CPhI Pharma Evolution Resources
Modernizing Drug Safety From Ingredients to Distribution
Today in the US alone, drug firms source nearly 40 percent of finished drugs, 80 percent of APIs, and perhaps ...
Annual Industry Report: Part 2
Industry Expert Panel Submissions
Annual Industry Report: Part 1
Industry Expert Panel Submissions
Formulation & Ingredients Management: Are You Really in Control?Featured Content Archive
Experts in API, excipients, and QbD commented on the survey results, offering a snapshot of industry practices ...
In Partnership With
Find quality, low cost ingredients & equipment
3-5 December 2013 | Mumbai, India
Register for your free expo pass today
Smart Pharma Video Symposium
Latest Archived Broadcast
Ed Silverman, renowned pharmaceutical industry journalist, discusses some of the high and low points of the past year.
Combating Counterfeit Drugs: Saving Lives, Saving Money
Read “Demystifying Track & Trace,” and learn how a single-source provider can help to ensure the safety of ...
Overcoming Formulation Challenges in the Development of Orally Disintegrating Tablets Consisting of Controlled-Release Multiparticulate Beads
This case study describes the development of controlled release multi-particulate beads for use in an ODT ...
Targeting PK and Patient Needs with Versatile, Timed-Based Oral Drug Delivery
Aptalis has enabled the successful leveraging of oral modified-release products in multiple therapeutic areas.
Aptalis Pharmaceutical Technologies: Patient Centric Drug Delivery
Aptalis offers oral delivery technology to produce tailored drug solutions with high patient acceptability.
Optimizing Drug Delivery Technology Partnerships
Pharmaceutical companies are taking advantage of drug technology experts earlier in the product development cycle.
Tastemasking Technology Platform (video)
Aptalis taste-masking and oral disintegrating tablet technologies offer flexibility and convenience for patients.
Overview of Service (video)
Aptalis offers products with integrated manufacturing and R&D solutions such as development and commercialization.
Customized Drug Release technology Platform (video)
Our custom drug release profiles can optimize performance such as providing rapid action or sustained release.
Biorise Bioavailability Enhancement Technology (video)
Biorise enables and improves the bioavailability of drugs and is proven to increase the rate of solubilization.
B. Braun Corporate VideoResources Archive
Take a fascinating look into the B. Braun world.
Mixed Progress During the Decade of Vaccines?InfoGraphics Archive
Pharma Evolution is looking for engaged readers to moderate the message boards on this site. Engage in high-IQ conversations; earn kudos and perks. Interested? E-mail: email@example.com
Highlighted Suppliers on CPHI Online
Visit the CPhI Online Directory to learn more about these suppliers:
Upcoming Live Events
Attend CPhl events to connect with the global pharma industry and identify business opportunities around the world:
9-11 April 2014
16-17 April 2014
20-22 May 2014
4-6 June 2014
26-28 June 2014
5-7 August 2014
7-9 October 2014
2-4 December 2014
Like Us on Facebook